                         SEQUENCE LISTING

<110>  Vaccinex, Inc.
       Smith, Ernest
       Shi, Shuying
 
<120>  IMPROVED METHODS FOR PRODUCING POLYNUCLEOTIDE LIBRARIES IN 
       VACCINIA VIRUS/EUKARYOTIC CELLS

<130>  58008-168081

<150>  US 62/370,009
<151>  2016-08-02

<160>  3     

<170>  PatentIn version 3.5

<210>  1
<211>  1555
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Transfer Plasmid containing pVHE promoter

<400>  1
ggccaaaaat tgaaaaacta gatctattta ttgcacgcgg ccgcaaacca tgggatggag       60

ctgtatcatc ctcttcttgg tagcaacagc tacaggcgcg catatggtca ccgtctcctc      120

agggagtgca tccgccccaa cccttttccc cctcgtctcc tgtgagaatt ccccgtcgga      180

tacgagcagc gtggccgttg gctgcctcgc acaggacttc cttcccgact ccatcacttt      240

ctcctggaaa tacaagaaca actctgacat cagcagcacc cggggcttcc catcagtcct      300

gagagggggc aagtacgcag ccacctcaca ggtgctgctg ccttccaagg acgtcatgca      360

gggcacagac gaacacgtgg tgtgcaaagt ccagcacccc aacggcaaca aagaaaagaa      420

cgtgcctctt ccagtgattg ctgagctgcc tcccaaagtg agcgtcttcg tcccaccccg      480

cgacggcttc ttcggcaacc cccgcagcaa gtccaagctc atctgccagg ccacgggttt      540

cagtccccgg cagattcagg tgtcctggct gcgcgagggg aagcaggtgg ggtctggcgt      600

caccacggac caggtgcagg ctgaggccaa agagtctggg cccacgacct acaaggtgac      660

tagcacactg accatcaaag agagcgactg gctcagccag agcatgttca cctgccgcgt      720

ggatcacagg ggcctgacct tccagcagaa tgcgtcctcc atgtgtgtcc ccgatcaaga      780

cacagccatc cgggtcttcg ccatcccccc atcctttgcc agcatcttcc tcaccaagtc      840

caccaagttg acctgcctgg tcacagacct gaccacctat gacagcgtca ccatctcctg      900

gacccgccag aatggcgaag ctgtgaaaac ccacaccaac atctccgaga gccaccccaa      960

tgccactttc agcgccgtgg gtgaggccag catctgcgag gatgactgga attccgggga     1020

gaggttcacg tgcaccgtga cccacacaga cctgccctcg ccactgaagc agaccatctc     1080

ccggcccaag ggggtggccc tgcacaggcc cgatgtctac ttgctgccac cagcccggga     1140

gcagctgaac ctgcgggagt cggccaccat cacgtgcctg gtgacgggct tctctcccgc     1200

ggacgtcttc gtgcagtgga tgcagagggg gcagcccttg tccccggaga agtatgtgac     1260

cagcgcccca atgcctgagc cccaggcccc aggccggtac ttcgcccaca gcatcctgac     1320

cgtgtccgaa gaggaatgga acacggggga gacctacacc tgcgtggtgg cccatgaggc     1380

cctgcccaac agggtcactg agaggaccgt ggacaagtcc accgaggggg aggtgagcgc     1440

cgacgaggag ggctttgaga acctgtgggc caccgcctcc accttcatcg tcctcttcct     1500

cctgagcctc ttctacagta ccaccgtcac cttgttcaag gtgaaatgag tcgac          1555


<210>  2
<211>  446
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Transfer plasmid containing pVKE promoter

<400>  2
ggccaaaaat tgaaaaacta gatctattta ttgcacgcgg ccgcccatgg gatggagctg       60

tatcatcctc ttcttggtag caacagctac acgggtgcac ttgactcgag atcaaacgaa      120

ctgtggctgc accatctgtc ttcatcttcc cgccatctga tgagcagttg aaatctggaa      180

ctgcctctgt tgtgtgcctg ctgaataact tctatcccag agaggccaaa gtacagtgga      240

aggtggataa cgccctccaa tcgggtaact cccaggagag tgtcacagag caggacagca      300

aggacagcac ctacagcctc agcagcaccc tgacgctgag caaagcagac tacgagaaac      360

acaaagtcta cgcctgcgaa gtcacccatc agggcctgag ctcgcccgtc acaaagagct      420

tcaacagggg agagtgttag gtcgac                                           446


<210>  3
<211>  455
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Transfer plasmid containing pVLE promoter

<400>  3
ggccaaaaat tgaaaaacta gatctattta ttgcacgcgg ccgcccatgg gatggagctg       60

tatcatcctc ttcttggtag caacagctac aggcgtgcac ttgactcgag aagcttaccg      120

tcctacgaac tgtggctgca ccatctgtct tcatcttccc gccatctgat gagcagttga      180

aatctggaac tgcctctgtt gtgtgcctgc tgaataactt ctatcccaga gaggccaaag      240

tacagtggaa ggtggataac gccctccaat cgggtaactc ccaggagagt gtcacagagc      300

aggacagcaa ggacagcacc tacagcctca gcagcaccct gacgctgagc aaagcagact      360

acgagaaaca caaagtctac gcctgcgaag tcacccatca gggcctgagc tcgcccgtca      420

caaagagctt caacagggga gagtgttagg tcgac                                 455


